SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > SQI Diagnostic Prospects

<< Previous

Bullboard Posts

Next >>

Comment by Blueseaon May 03, 2023 5:34pm

185 Views

Post# 35428627

RE:SQI Diagnostic Prospects

Here is my opinion...

The owners know that they are sitting on a gold mine. Once the commercialization becomes a reality, everyone will see the true of value of this company. My sense is that they may not be interested in outside investors at this time, because they can self finance the next steps. The commercialization of there products will speak louder than words. The FDA approvals will be game changers. Just my opinion.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments